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ScienceDirectThe trans-Atlantic slave trade brought millions of Africans to the
New World. Advances in genomics are providing novel insights
into the history and health of Africans and the diasporan
populations. Recent examples reviewed here include the
unraveling of substantial hunter-gatherer and ‘Eurasian’
admixtures across sub-Saharan Africa, expanding our
understanding of ancestral African genetics; the global ubiquity
of mixed ancestry; the revealing of African ancestry in Latin
Americans that likely derived from the slave trade; and
understanding of the ancestral backgrounds of APOL1 and LPL
found to influence kidney disease and lipid levels, respectively,
providing specific insights into disease etiology and health
disparities.
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Introduction
Anatomically modern humans originated in Africa before
migrating to populate the rest of the world in the last
100 000 years, hence the expression ‘we are all Africans
beneath our skin’ [1,2]. This generally accepted consen-
sus begs the question of why is the global dispersion of
some human populations out of Africa referred to as the
‘African Diaspora’ and others are not? Who and from
where are these groups that constitute the African Dias-
pora and how has their history shaped patterns of genomic
variation, the distribution of fitness influencing muta-
tions, and health? Here, we review recent data on these
questions and explore how these data, especially the
accelerated cataloging of global human genetic variation,
are informing our understanding of the identities and
health of these populations in their current homelands.www.sciencedirect.com We illustrate opportunities offered by the African Dias-
pora to study interactions of old genes with modern
environments, thereby lending novel insights into disease
etiology, ancestry-based disease gene mapping, and
health disparities.
The African diaspora — history and definition
The term ‘African Diaspora’ first appeared in the litera-
ture in the 1950s and has been broadly defined to include
all global communities descended from the historic
migrations of peoples from Africa since the 15th century
[3,4]. This delineates it from the pre-historic Out-of-
Africa migrations that led to the peopling of the world.
The African Diaspora has also been more narrowly de-
fined to include only the trans-Atlantic slave trade. This
narrower definition, which emphasizes the important
roles that blackness, slavery, colonialism, racism, and
geography played in sustaining the trans-Atlantic slave
trade, is the reason why some refer to the ‘African
Diaspora’ as the ‘Black Diaspora’ [3,5]. The trans-Atlantic
slave trade was the single largest immigration of Africans
from the Old World to the New World. The first leg of the
triangular trade involved ships from Europe carrying
goods (e.g., iron, brandy, weapons, and gunpowder) that
were traded for slaves in Africa. The second leg, termed
the Middle Passage, involved the shipment of between
12 and 14 million enslaved Africans across the Atlantic
Ocean to the Americas. The last leg was the transporta-
tion of goods (e.g., sugar, cotton, tobacco, rum, and mo-
lasses) from the Americas to Europe.
Most enslaved Africans were brought to European colo-
nies in Latin America, while 3–5% were brought to the
United States of America (USA) [6]. These enslaved
Africans and their descendants in the USA represent
the group ‘African Americans’. As with other diasporan
populations and indeed most of the world populations
[7], African Americans have multiple ancestries with
lineages from Africa, Europe, Asia, and Native America
among others. Hence, the term ‘African American’ is not a
genetically homogeneous entity as reflected in the fact
that self-identified African Americans include individuals
ranging from almost no African ancestry to almost no
European ancestry [8,9] (Figure 1). In addition, cultural
diversity abounds in the descendants of the African
Diaspora as exemplified by Brazilians. With over 4 million
slaves, Brazil has long been a melting pot of ancestries and
cultures, as evidenced by the blending of African and
European religions (Candomble, Catholicism), foods
(Feijoada), music, and dance (Samba). A recent censusCurrent Opinion in Genetics & Development 2016, 41:77–84
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Figure 1
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Individual admixture proportions from New World samples [12]. The six samples are African Caribbean in Barbados (ACB), People with African
Ancestry in Southwest USA (ASW), Puerto Ricans in Puerto Rico (PUR), Colombians in Medellı´n, Colombia (CLM), People with Mexican Ancestry
in Los Angeles, California (MXL), and Peruvians in Lima, Peru (PEL). Conditional on eight ancestries, yellow corresponds to Western African
ancestry, aquamarine corresponds to West-Central African ancestry, blue corresponds to Southern European ancestry, orange corresponds to
Northern European ancestry, purple corresponds to Native American ancestry, red corresponds to South Asian ancestry, green corresponds to
East Asian ancestry, and black corresponds to Southeastern Asian ancestry. Summing the Western and West-Central African ancestries, the
range of individual admixture proportion across these six samples goes from 0% to 97.8%. Similarly, the range of individual admixture proportion
for Native American ancestry goes from 0% to 100%.indicates that about 50% of the 200 million Brazilians
self-identify as persons of African ancestry or mixed
ancestry [10]. These mixtures of ancestries, acquired over
hundreds of years, have serious implications for national
and global biomedical initiatives such as precision medi-
cine because phenotypic appearances and self and group
identification are unlikely to adequately capture the
ancestral backgrounds of individuals that make up the
African Diaspora.
Population structure and genetic diversity
among African populations
The landscape of population structure and genetic diver-
sity of sub-Saharan Africans (SSA) was recently illumi-
nated by two large international projects: the African
Genome Variation Project (AGVP) [11] and the
1000 Genomes Project [12]. The AGVP data, generated
from 20 African ethno-linguistic groups, revealed previ-
ously unappreciated population structure, including re-
gionally distinct patterns of admixture. Using principal
components analysis, unsupervised cluster analysis, andCurrent Opinion in Genetics & Development 2016, 41:77–84 the f3 test for admixture, evidence for substantial ‘Eur-
asian’ and hunter-gatherer admixture was observed across
SSA [11]. The timing and sources of admixture were
regionally distinct, with admixture in West Africans dat-
ing to 9000 years ago and a source similar to present-day
Khoe-San populations and with admixture in East Afri-
cans dating to 3000 years ago and a source similar to
Mbuti rainforest hunter-gatherer populations [11].
African populations are highly subdivided, with popula-
tion structure across Africa currently recognized as
11 ancestries that correspond to a combination of geo-
graphic and linguistic separation: Khoisan in southern
Africa; Central African, predominant in Pygmies; Hadza
in Tanzania; Western African, predominant in Mande-
speaking peoples; West-Central African, predominant in
both Bantu-speaking and non-Bantu-speaking peoples in
the area from Ghana to Cameroon; and ancestries corre-
sponding to speakers of Berber, Cushitic, Eastern Bantu,
Omotic, Nilo-Saharan, and Southern Bantu languages
[7,11,13]. By comparison, 12 ancestries have beenwww.sciencedirect.com
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north-to-south differentiation in Europe and one that
encompasses Native American ancestry [7]. Genetic
differentiation, measured by FST, between SSA ancestries
can exceed that between pairs of non-African ancestries.
For example, FST is 0.054 between Khoisan and Omotic
ancestries, compared to 0.024 between Southern and
Northern European ancestries or 0.042 between Arabian
and Indian ancestries [7].
Higher levels of genetic diversity are observed among
SSA. The number of variant sites per individual of SSA
ancestry is 5 million, compared to 4.0–4.2 million
variants per individual of East Asian, European, or South
Asian ancestry [12]. The average rate of nucleotide
differences of 1.2 per kilobase between a pair of Khoe-
San individuals exceeds that of 1.0 per kilobase between
an Asian individual and a European individual [14]. As a
function of physical distance, linkage disequilibrium
decays faster in SSA populations than in non-African
populations [12], such that haplotypes are shorter in
SSA. Lower burdens of runs of homozygosity tend to be
observed in SSA ancestry populations, as well as in
admixed populations [15], leading to lower risk of auto-
somal recessive diseases.
Genomic profile of contemporary populations
of the African diaspora
In admixed African Americans, continental-level differ-
ences between Africans and Europeans can explain up to
8% of phenotypic variance across a range of anthropomet-
ric and cardio-metabolic traits [16]. Given the progress in
delineating population structure at the sub-continental
level described above, a deeper understanding of the
fine-scale genetic structure in African Diaspora popula-
tions is needed. Western African ancestry is the predomi-
nant ancestry in the Mende people from Sierra Leone and
Jola, Mandinka, and Wolof peoples from The Gambia
[11,12]. West-Central African ancestry is the predomi-
nant ancestry in non-Bantu-speaking peoples such as the
Ga-Adangbe peoples from Ghana and the Esan, Igbo, and
Yoruba peoples from Nigeria [11,12]. Among Bantu-
speaking peoples, genetic differentiation following the
Bantu expansion gave rise to distinct ancestries in West-
Central Africa (found in Bamum and M’fang peoples in
Cameroon and Kongo people from the Democratic Re-
public of the Congo), Eastern Africa (found in Baganda,
Barundi, and Banyarwanda peoples from Uganda and
Luhya and Kikuyu peoples from Kenya), and Southern
Africa (found in Sotho and Zulu peoples from South Africa)
[7,8,11]. At the Y DNA level, Western Africans have
comparatively more E1b1a1a1f, whereas West-Central
Africans have comparatively more E1b1a1a1g [12].
These findings of regional ancestry within continental
Africa indicate that some degree of localization of African
origin for African Americans and other diasporan Africans
is possible.www.sciencedirect.com The genomic profile of contemporary populations of the
Americas reflects admixture that occurred among Eur-
opeans, Native Americans, and enslaved Africans in the
New World. For several reasons, including where slaves
disembarked and socio-cultural practices such as ances-
try-positive assortative mating, the average percentage of
African ancestry in the Americas varies widely. Recent
estimates range from 87% in African Caribbeans from
Barbados, 75% in African Americans in Southwest USA,
19% in Puerto Ricans, 12% in Colombians in Medellı´n,
7% in people with Mexican ancestry in Los Angeles, and
4% in both Peruvians in Lima and Argentinians sampled
from across Argentina [12,17] (Figure 1). African ances-
try in the Caribbean appears consistent with two waves,
the first from Western Africa followed by the second from
West-Central Africa [18]. In Spanish-speaking South
America, African ancestry averages 5% [19]. In Brazil,
African ancestry varies from 51% in Salvador in the
Northeast to 15% in Bambuı´ in the Southeast and 16%
in Pelotas in the South [20]. Western African and West-
Central African ancestries are more prevalent in North-
eastern Brazil due to a larger proportion of disembarka-
tion from Western and West-Central Africa in Salvador
whereas Eastern African ancestry is more prevalent in the
Southeast and South due to a larger proportion of disem-
barkation from Mozambique in Rio de Janeiro [20].
Population structure in the Americas displays further
complexity by the widely varied average percentage of
Native American ancestry in these populations, with
about 1% in African Caribbeans from Barbados, 4% in
African Americans in Southwest USA, 15% in Puerto
Ricans, 28% in Colombians in Medellı´n, 49% in people
with Mexican ancestry in Los Angeles, and 78% in
Peruvians in Lima [12] (Figure 1).
Genetic signals of natural selection and
implications for health and disease
Genetic adaptations that took place across Africa, partic-
ularly against fatal pathogens and ecological forces, have
resulted in elevated frequencies of alleles conferring
survival advantages detectable in present-day African
ancestry individuals on the continent and in the Diaspora
(Table 1) [21,22,23,24,25,26]. Unfortunately, some of
these alleles are maladaptive in modern-day environ-
ments. The discordance between ancestral genetic back-
ground and modern-day environmental exposures
became pronounced in the African Diaspora, contributing
to the disproportionately high burden of some chronic
diseases and health disparities in these groups.
A recent striking example of the evolutionary importance
of genetic variants in populations of the African Diaspora,
with implications for health disparities, is the link be-
tween kidney disease, African sleeping sickness, and two
missense haplotypes called G1 (consisting of S342G and
I384M) and G2 (delN388/Y389) in the gene Apolipopro-
tein L1 (APOL1) [27,28]. The initial studies that linkedCurrent Opinion in Genetics & Development 2016, 41:77–84
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Table 1
Examples of natural selection with implications for human health
Adapted Genes Beneficial Trait Negative Outcome References
APOL1 Protection against Human
African Trypanosomiasis (HAT)
Kidney disease [27,28,29,30,31,32,
33,34,35,36,49]
ATP1A1, AQP2, CSK Climate adaptation Hypertension and osmoregulation [11,37,38]
PPARA Energy metabolism during
prolonged food deficiency
None known to date [50]
CIC, PAFAH1B3, LIPE,
BHLHE41
High altitude adaptation None known to date [25,26]
LARGE, IL21 Confers protection against
the Lassa virus
None known to date [51]
DMD Confers protection against
the Lassa virus
1) Increased replication of vaccinia virus. 2)
Duchenne and Becker muscular dystrophy
[52]
DARC Confers resistance to P. vivax Benign ethnic neutropenia [53,54,55,56,57,58,59]
HBB Confer incomplete resistance
to lethal forms of malaria
Sickle Cell Trait and Sickle Cell Disease [60,61,62,63,64,65]
Regulatory deficiencies
of HBA and HBB
Confers incomplete resistance
to lethal forms of malaria
a and b thalassemia [66,67]
CCR5 D32 deletion Confers HIV protection 1) CCR5 D32 are at higher risk for tick-borne
encephalitis. 2) Fully functional CCR5 reduces
symptoms from infection with West Nile virus
[68,69,70,71]
LCT Lactase persistence None known to date [21,72,73]
AMY1 Increased copies of the gene in areas
where starch is consumed
None known to date [74]this genomic region to kidney diseases took advantage of
the demographic history of African Americans by con-
ducting admixture mapping [29,30]. The two renal dis-
ease risk haplotypes are present at relatively high
frequency in individuals of recent African ancestry (espe-
cially from West-Central Africa where the trypanosome
parasite is endemic) but are absent in Europeans and
Asians. These observations, and the known trypanolytic
activity of the variants against Trypanosoma brucei rhode-
siense, have led to the hypothesis that these variants
evolved in SSA and have risen to high frequency because
they confer protection against a deadly form of African
sleeping sickness [27]. Interestingly, these African-spe-
cific renal risk variants are also seen in the Americas as a
result of admixture since the trans-Atlantic slave trade
[28,31] (Figure 2). G1 and G2 haplotypes recapitulate the
molecular characteristics of APOL1 in Old World mon-
keys, and innate immune activity afforded by APOL1
may extend beyond trypanosomes [32]. S342G has the
highest frequency in West-Central Africa, whereas G2 is
more evenly distributed and at lower frequency through-
out SSA (Figure 2). S342G was the most differentiated
locus (P = 5.11  107) in a genome-wide comparison of
the Western African Yoruba and the Eastern African
Luhya ethnic groups, suggesting the role of positive
selection in the evolution of the locus [32]. Clinically,
kidney transplant failure is higher in recipients of donor
kidneys from African ancestry individuals carrying APOL1
renal risk variants [33]. APOL1 high-risk genotypes (i.e.,
two risk alleles) explain an estimated 7-37% variance and
52-68% population attributable risk for different forms of
end-stage kidney disease [34]. The APOL1 variants have
also been implicated in cardiovascular diseases (CVD)Current Opinion in Genetics & Development 2016, 41:77–84 [35]. Individuals of African ancestry with the risk geno-
type display less protection against kidney disease from
HDL compared to Europeans and Asians [36].
Ecological adaptations to tropical climate have also
shaped the genetic structure of Africans. Local tempera-
ture-induced adaptive genetic changes may be one mech-
anism involved in hypertension and differences in salt
sensitivity in humans [37]. Heat-adapted people, partic-
ularly members of the African Diaspora, have greater risk
of hypertension due to exposures of the modern world
(e.g., increased salt intake) interacting with ancestral
susceptibility [37]. Consistent with this hypothesis, sig-
nals of selection have been detected in ATP1A1, AQP2,
and CSK genes previously implicated in hypertension and
osmoregulation [11]. The ancestral allele of the CSK
locus displaying high differentiation among African popu-
lations is strongly correlated with hypertension risk and its
frequency is inversely correlated with latitude [11].
These findings support the hypothesis that adaptation
to climate produced a latitudinal cline in hypertension
susceptibility. If validated with more mechanistic studies,
these observations could provide significant insight into
the pathogenesis of hypertension. However, the ubiquity
of exposure to environmental risk factors for hypertension
at the global level is likely to make validating this
hypothesis difficult; some of the highest rates of hyper-
tension have been observed in non-African Diaspora
populations [38].
Climatic adaptations in low latitude and high ultraviolet
radiation (UVR) regions of the tropics are thought to have
maintained dark skin pigmentation to protect againstwww.sciencedirect.com
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Geographic distribution of Trypansoma brucei and APOL1 risk variants. (a) Cumulative incidence from 1990 to 2014 of human African
trypanosomiasis due to Trypansoma brucei gambiense (gHAT) and Trypanosoma brucei rhodesiense (rHAT) [75]. Uganda is the only country
reporting trypanosomiasis due to both subspecies, with a higher cumulative incidence of gHAT. (b) Global frequency distribution of the G allele of
the S342G mutation [11,12,28,49,76,77,78]. The Esan in Nigeria have the highest frequency (49.5%). (c) Global frequency distribution of the G2
deletion [12,28,32,49,77]. Bantu-speaking people in South Africa (Herero, Ovambo, Pedi, Sotho, Tswana, and Zulu) have the highest frequency
(21.4%).UVR-induced DNA damage and folate photolysis [39].
After modern humans migrated out of Africa, the chal-
lenges of producing vitamin D in the skin from the low
UVR outside of the tropics were met by natural selection
acting on mutations producing skin depigmentation more
than 30,000 years ago [40]. Dark skin pigmentation is
maladaptive in low UVR environments, potentially con-
tributing to health disparities in diseases associated with
vitamin D deficiency including several forms of cancer
and cardiometabolic diseases [41]. Future mechanistic
studies are needed to disentangle the effects of the
ancestral alleles of genes selected for skin pigmentation
from those of dietary and lifestyle changes leading to
vitamin D deficiency and related co-morbidities.www.sciencedirect.com Novel insights into disease etiology have also been gained
by comparing diasporan populations to their ancestral
populations in SSA and by characterizing local admixture
at disease risk loci. A recent study found that the associa-
tion between the LPL SNP rs328 and lipid levels was
stronger and the levels of HDL cholesterol were higher
among African Americans with predominantly European
ancestry than among those with African ancestry at this
locus [42]. Lipid levels and their association with the LPL
variant in African Americans with two African ancestry
alleles at this locus were similar to those of West Africans
despite widely different lifestyles and diets [42]. Another
example of disease-associated alleles introduced to the
Americas during the trans-Atlantic slave trade is theCurrent Opinion in Genetics & Development 2016, 41:77–84
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osteogenesis imperfecta, so far found only in African
Americans and West Africans [43]. This LEPRE1 muta-
tion arose in West Africa more than 650 years ago and was
transported to the Americas during the trans-Atlantic
slave trade. Approximately 0.4% of African Americans
and 1.5% of Nigerians and Ghanaians are heterozygous
carriers [43].
Call for large-scale deep sequencing across
the African continent and the diaspora
Earlier genotyping arrays were less efficient for interrogat-
ing the genomes of African ancestry populations [44] due
to the fact that greater genetic variation is seen in present-
day Africa populations than in populations outside of the
continent, resulting in an increased number of haplotypes,
lower levels of linkage disequilibrium (LD), more diver-
gent patterns of LD, and more complex patterns of popu-
lation substructure [11,12,13]. For example, our recent
whole-genome sequencing effort in 320 SSA identified
about 30 million variants [11], of which up to a quarter
were unobserved in other populations from the 1000 Gen-
omes sequencing project [12], indicating a need for large-
scale deep sequencing of diverse populations across SSA
and a need for a better genotyping array. Although some
efforts have been made to address these concerns, includ-
ing the recent development of the Infinium Multi-Ethnic
Genotyping Array (MEGA) and the Affymetrix1 Axi-
om1 Genome-Wide Pan-African (PanAFR) Array, there
remains a need for the development of a pan-African
genotyping array that captures a larger proportion of com-
mon genetic variation across diverse African populations
[11]. To achieve this goal, the H3Africa consortium has
joined with the Wellcome Trust Sanger Institute, Illu-
mina, and others to develop a genotyping array by interro-
gating whole-genome sequences from over 4,000 Africans
sampled across the continent. There is also a need for
improvements in algorithms for ancestry inference from
whole-genome sequence data. Methodological issues in-
clude accounting for uncertain genotypes [45,46], linkage
disequilibrium and phase [47], low-coverage sequence
reads [48], and inadequate or missing source populations.
Conclusion
The history of the African Diaspora as defined in this
opinion piece is complex, dynamic and continuous. With
Africa at its root, members of the Diaspora developed
multifaceted religious, cultural, and socio-political char-
acteristics to adapt and survive in their new environ-
ments. As demonstrated above, genomics is beginning
to facilitate better understanding of these multi-layered
stories and their implications for human history and
health. However, more comprehensive sampling and
genetic characterization of the populations of the African
Diaspora and their ancestral homelands is urgently need-
ed if these groups are to benefit from genomic medicine.Current Opinion in Genetics & Development 2016, 41:77–84 Acknowledgments
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